Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Mundipharma K.K.
Sponsor:
Information provided by (Responsible Party):
Mundipharma K.K.
ClinicalTrials.gov Identifier:
NCT01776411
First received: January 22, 2013
Last updated: February 13, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)